Pipeline
Device Flow Diversion
PDI 00847536016903
General payments
$4,014,083
Research payments
$2,246,461
Through program year 2025, $4,014,083 in general payments and $2,246,461 in research payments were reported against Pipeline (Flow Diversion).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,061,569 | 3,091 |
| 2025 | Research | $699,047 | 240 |
| 2024 | General | $910,557 | 2,735 |
| 2024 | Research | $528,329 | 119 |
| 2023 | General | $853,354 | 3,043 |
| 2023 | Research | $551,780 | 97 |
| 2022 | General | $677,678 | 2,182 |
| 2022 | Research | $375,432 | 28 |
| 2021 | General | $510,925 | 2,026 |
| 2021 | Research | $91,874 | 2 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
13,077 general · 486 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.